1. 172P Phase I study of JTX-8064, a LILRB2 (ILT4) inhibitor, as monotherapy and combination with pimivalimab (pimi), a PD-1 inhibitor (PD-1i), in patients (pts) with advanced solid tumors. (December 2022) Authors: Papadopoulos, K.; Li, T.; Lakhani, N.; Powderly, J.; George, T.; Teoh, D.G.K.; Kilari, D.; Giaccone, G.; Sanborn, R.E.; Ghamande, S.; LoRusso, P.; Gibney, G.; Ma, V.T-L.; Yalamanchili, K.; Brown, J.; Mota, N.; Tasillo Kadra, C.; Umiker, B.; Xiao, X.; Trehu, E. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 330 First-in-man study of gemcitabine hydrochloride oral formulation (D07001-F4) in patients with malignant tumors. (September 2015) Authors: Gabrail, N.; Ghamande, S.; Silverman, M.; Smith, C.; Ho, H.L.; Huang, C.T.; Hsueh, S.P.; Lin, C.L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up. Issue 4 (1st June 2004) Authors: Odunsi, K.; Moneke, V.; Tammela, J.; Ghamande, S.; Seago, P.; Driscoll, D.; Marchetti, D.; Baker, T.; Lele, S. Journal: International journal of gynecological cancer Issue: Volume 14:Issue 4(2004) Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer. Issue 2 (1st February 2003) Authors: Ghamande, S.; Lele, S.; Marchetti, D.; Baker, T.; Odunsi, K. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 2(2003) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗